Cipla Ltd on Thursday reported a net profit of Rs 292 crore for the quarter ended March 31, compared to Rs 214 crore, a rise of 36 per cent. Gross revenue grew by 12 per cent to Rs 1,890 from Rs 1,687 crore. Domestic revenue grew by 15 per cent to Rs 855 crore from Rs 652 crore, on account of growth in anti-asthma, anti-biotics therapy segments.
Top Section
Explore Business Standard